Show simple item record

dc.contributor.authorDoebele, R
dc.contributor.authorAhn, M
dc.contributor.authorSiena, S
dc.contributor.authorDrilon, A
dc.contributor.authorKrebs, Matthew G
dc.contributor.authorLin, C
dc.contributor.authorDe, Braud, F
dc.contributor.authorJohn, T
dc.contributor.authorTan, D
dc.contributor.authorSeto, T
dc.contributor.authorDziadziuszko, R
dc.contributor.authorArkenau, H
dc.contributor.authorBarlesi, F
dc.contributor.authorRolfo, C
dc.contributor.authorWolf, J
dc.contributor.authorChow-Maneval, E
dc.contributor.authorMultani, P
dc.contributor.authorCui, N
dc.contributor.authorRiehl, T
dc.contributor.authorCho, BC
dc.date.accessioned2019-02-08T15:20:03Z
dc.date.available2019-02-08T15:20:03Z
dc.date.issued2018en
dc.identifier.citationDoebele R, Ahn M, Siena S, Drilon A, Krebs M, Lin C, et al. OA02.01Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). J Thorac Oncol. 2018 Oct;13(10):S321-S322.en
dc.identifier.doi10.1016/j.jtho.2018.08.239en
dc.identifier.urihttp://hdl.handle.net/10541/621485
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jtho.2018.08.239en
dc.titleEfficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Colorado, Aurora, CO/USen
dc.identifier.journalJournal of Thoracic Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record